Poupon-Bejuit, Laura;
Geard, Amy;
Millicheap, Nathan;
Rocha-Ferreira, Eridan;
Hagberg, Henrik;
Thornton, Claire;
Rahim, Ahad A;
(2024)
Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy.
EMBO Molecular Medicine
10.1038/s44321-024-00079-1.
(In press).
Preview |
Text
Rahim_poupon-bejuit-et-al-2024-diabetes-drugs-activate-neuroprotective-pathways-in-models-of-neonatal-hypoxic-ischemic.pdf Download (4MB) | Preview |
Abstract
Hypoxic-ischaemic encephalopathy (HIE) arises from diminished blood flow and oxygen to the neonatal brain during labor, leading to infant mortality or severe brain damage, with a global incidence of 1.5 per 1000 live births. Glucagon-like Peptide 1 Receptor (GLP1-R) agonists, used in type 2 diabetes treatment, exhibit neuroprotective effects in various brain injury models, including HIE. In this study, we observed enhanced neurological outcomes in post-natal day 10 mice with surgically induced hypoxic-ischaemic (HI) brain injury after immediate systemic administration of exendin-4 or semaglutide. Short- and long-term assessments revealed improved neuropathology, survival rates, and locomotor function. We explored the mechanisms by which GLP1-R agonists trigger neuroprotection and reduce inflammation following oxygen-glucose deprivation and HI in neonatal mice, highlighting the upregulation of the PI3/AKT signalling pathway and increased cAMP levels. These findings shed light on the neuroprotective and anti-inflammatory effects of GLP1-R agonists in HIE, potentially extending to other neurological conditions, supporting their potential clinical use in treating infants with HIE.
| Type: | Article |
|---|---|
| Title: | Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s44321-024-00079-1 |
| Publisher version: | https://doi.org/10.1038/s44321-024-00079-1 |
| Language: | English |
| Additional information: | © 2024 The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Creative Commons Public Domain Dedication waiver http://creativecommons.org/publicdomain/zero/1.0/ applies to the data associated with this article, unless otherwise stated in a credit line to the data, but does not extend to the graphical or creative elements of illustrations, charts, or figures. This waiver removes legal barriers to the re-use and mining of research data. According to standard scholarly practice, it is recommended to provide appropriate citation and attribution whenever technically possible. |
| Keywords: | GLP1-R Agonists; Semaglutide; Exendin-4; Neonatal Hypoxicischaemic Encephalopathy; Neuroprotective Mechanisms |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10193087 |
Archive Staff Only
 |
View Item |
